Global Medical Tourism Market Research Report Information by Treatment Type, by Service Provider, and by Region Forecast till 2035

Description

List of Tables

With a CAGR of 18.02% from 2025 to 2035, the Medical Tourism Market is expected to attain a valuation of USD 2,92,866.10 million by 2035. Medical tourism is the seeking of medical or healthcare services abroad or outside the region of one's residence.

Government Promotion and Credibility Building

National medical tourism campaigns have increased the level of trust towards foreign healthcare systems which in turn has led to more international patient inflows.

Medical Tourism Market Major Sub-Segments

Treatment Type

Orthopaedic: Advanced orthopedic surgeries with global expertise
Oncology: Specialized cancer care at competitive pricing
Cosmetic Surgery: Internationally recognized aesthetic treatment options
Epilepsy: Targeted epilepsy care using advanced diagnostics
Cardiovascular: World-class cardiac care and interventions
Dentistry: Affordable dental tourism with quality assurance
Neurology: Precision treatments for complex neurological disorders
Fertility: Cost-effective fertility treatments with global demand
Others: Broad range of specialized medical procedures

Service Provider

Public: Accessible healthcare services backed by governments
Private: Technology-driven hospitals catering international patients

Regional Insights

North American and European markets essentially serve as the main sources while the Asia-Pacific region, being the medical hub, takes the lead in medical tourism. Besides the Middle East, other regions are also gaining momentum due to the infrastructural investments.

Market Restraints

Apprehensions about follow-ups after the treatment, safety standards, quality of services and ethical practices still restrain the market from extending its influence.

Key Report Attributes

Market Size 2024: USD 49,279.57 Million
Market Size 2035: USD 2,92,866.10 Million
CAGR (2025-2035): 18.02%
Base Year: 2024
Market Forecast Period: 2025-2035

Industry Segmentations Growth

By Treatment Type: Orthopaedic - 16.11%, Oncology - 14.41%.
By Service Provider: Public - 16.25%, Private - 18.94%.

Product Code: MRFR/MED/1443-CR

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 OVERVIEW
3.2 DATA FLOW
- 3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
- 3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
- 3.5.1 PRIMARY RESEARCH DATA FLOW:
- 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
- 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.6.1 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
- 3.7.1 DATA FORECASTING TYPE
3.8 DATA MODELING
- 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
- 3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

4.1 INTRODUCTION
4.2 DRIVERS
- 4.2.1 RISING AWARENESS ABOUT MEDICAL TOURISM AMONG PATIENTS
- 4.2.2 LOW COST OF MEDICAL TREATMENT IN DEVELOPING COUNTRIES
4.3 RESTRAINTS
- 4.3.1 ISSUE WITH PATIENT FOLLOW-UP AND POST-SURGERY COMPLICATIONS
- 4.3.2 QUALITY, SAFETY, AND ETHICAL CONCERNS
4.4 OPPORTUNITY
- 4.4.1 EXPANSION OF TELEMEDICINE AND VIRTUAL CONSULTATIONS
- 4.4.2 CROSS-BORDER COLLABORATIONS AND HOSPITAL PARTNERSHIPS

5 INDUSTRY TREND ANALYSIS

5.1 REGULATORY ENVIRONMENT & COMPLIANCE
5.2 MARKET TRENDS & INNOVATION
5.3 MARKET ENTRY & EXIT BARRIERS
- 5.3.1 BARRIERS TO ENTRY
- 5.3.2 BARRIERS TO EXIT
5.4 PRICING ANALYSIS & REIMBURSEMENT DYNAMICS
- 5.4.1 PRICING ANALYSIS
  - 5.4.1.1 NORTH AMERICA
    - 5.4.1.1.1 NORTH AMERICA PRICING ANALYSIS, BY PROCEDURE
  - 5.4.1.2 EUROPE
    - 5.4.1.2.1 EUROPE PRICING ANALYSIS, BY PROCEDURE
  - 5.4.1.3 APAC
    - 5.4.1.3.1 APAC PRICING ANALYSIS, BY PROCEDURE
  - 5.4.1.4 REST OF THE WORLD
    - 5.4.1.4.1 REST OF THE WORLD PRICING ANALYSIS, BY PROCEDURE
- 5.4.2 REIMBURSEMENT DYNAMICS
5.5 PARTNERSHIPS & COLLABORATIONS
5.6 PESTLE ANALYSIS
- 5.6.1 POLITICAL FACTORS
- 5.6.2 ECONOMIC FACTORS
- 5.6.3 SOCIAL FACTORS
- 5.6.4 TECHNOLOGICAL FACTORS
- 5.6.5 LEGAL FACTORS
- 5.6.6 ENVIRONMENTAL FACTORS
5.7 PORTER'S FIVE FORCES MODEL
- 5.7.1 THREAT OF NEW ENTRANTS
- 5.7.2 BARGAINING POWER OF SUPPLIERS
- 5.7.3 THREAT OF SUBSTITUTES
- 5.7.4 BARGAINING POWER OF BUYERS (PATIENTS)
- 5.7.5 INTENSITY OF RIVALRY
5.8 CASE STUDY ANALYSIS
5.9 INVESTMENT & FUNDING SCENARIOS
5.10 LIST OF KEY PLAYERS, BY COUNTRY
- 5.10.1 THAILAND
  - 5.10.1.1 LIST OF KEY PLAYERS, THAILAND
- 5.10.2 INDIA
  - 5.10.2.1 LIST OF KEY PLAYERS, INDIA
- 5.10.3 MEXICO
  - 5.10.3.1 LIST OF KEY PLAYERS, MEXICO
- 5.10.4 TURKEY
  - 5.10.4.1 LIST OF KEY PLAYERS, TURKEY
- 5.10.5 MALAYISA
  - 5.10.5.1 LIST OF KEY PLAYERS, MALAYSIA
5.11 QUALITATIVE DATA ON MEDICAL TOURISM ESPECIALLY THE DENTAL TOURISM DATA
- 5.11.1 THAILAND
  - 5.11.1.1 COSTS INVOLVED IN THAILAND DENTAL TOURISM
- 5.11.2 INDIA
  - 5.11.2.1 COSTS INVOLVED IN INDIAN DENTAL TOURISM
- 5.11.3 TURKEY
  - 5.11.3.1 COSTS INVOLVED IN TURKEY DENTAL TOURISM
5.12 QUALITATIVE ANALYSIS OF LEADING ECONOMIES IN MEDICAL TOURISM
- 5.12.1 INDIA
  - 5.12.1.1 KEY REASONS
  - 5.12.1.2 KEY TRENDS
- 5.12.2 THAILAND
  - 5.12.2.1 KEY REASONS
  - 5.12.2.2 KEY TRENDS
- 5.12.3 SINGAPORE
  - 5.12.3.1 KEY REASONS
  - 5.12.3.2 KEY TRENDS
- 5.12.4 MEXICO
  - 5.12.4.1 KEY REASONS
  - 5.12.4.2 KEY TRENDS
5.13 MAJOR OUTBOUND MEDICAL TOURISM ANALYSIS, 2024

6 GLOBAL MEDICAL TOURISM MARKET, BY TREATMENT TYPE

6.1 OVERVIEW
6.2 ORTHOPAEDIC
6.3 OPHTHALMOLOGY
6.4 ONCOLOGY
6.5 COSMETIC SURGERY
6.6 CARDIOVASCULAR
6.7 DENTISTRY
6.8 NEUROLOGY
6.9 FERTILITY
6.10 OTHERS

7 GLOBAL MEDICAL TOURISM MARKET, BY SERVICE PROVIDER

7.1 OVERVIEW
7.2 PUBLIC
7.3 PRIVATE

8 GLOBAL MEDICAL TOURISM MARKET, BY REGION

8.1 OVERVIEW
8.2 NORTH AMERICA
- 8.2.1 US
- 8.2.2 CANADA
8.3 EUROPE
- 8.3.1 GERMANY
- 8.3.2 FRANCE
- 8.3.3 UK
- 8.3.4 ITALY
- 8.3.5 SPAIN
- 8.3.6 REST OF EUROPE
8.4 ASIA-PACIFIC
- 8.4.1 CHINA
- 8.4.2 INDIA
- 8.4.3 JAPAN
- 8.4.4 AUSTRALIA
- 8.4.5 SOUTH KOREA
- 8.4.6 REST OF ASIA-PACIFIC
8.5 REST OF THE WORLD
- 8.5.1 MIDDLE EAST
- 8.5.2 AFRICA
  - 8.5.2.1 TUNISIA
  - 8.5.2.2 MOROCCO
  - 8.5.2.3 KENYA
  - 8.5.2.4 EGYPT
  - 8.5.2.5 SOUTH AFRICA
  - 8.5.2.6 REST OF AFRICA
- 8.5.3 SOUTH AMERICA

9 COMPETITIVE LANDSCAPE

9.1 INTRODUCTION
9.2 MARKET SHARE ANALYSIS, 2024
9.3 COMPETITOR DASHBOARD
9.4 PUBLIC PLAYERS STOCK SUMMARY
9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL
9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 9.6.1 RECOGNITION
- 9.6.2 FACILITY EXPANSION

10 COMPANY PROFILES

10.1 APOLLO HOSPITALS
- 10.1.1 COMPANY OVERVIEW
- 10.1.2 FINANCIAL OVERVIEW
- 10.1.3 PRODUCTS OFFERED
- 10.1.4 KEY DEVELOPMENTS
- 10.1.5 SWOT ANALYSIS
- 10.1.6 KEY STRATEGIES
10.2 BUMRUNGRAD INTERNATIONAL HOSPITAL
- 10.2.1 COMPANY OVERVIEW
- 10.2.2 FINANCIAL OVERVIEW
- 10.2.3 PRODUCTS OFFERED
- 10.2.4 KEY DEVELOPMENTS
- 10.2.5 SWOT ANALYSIS
- 10.2.6 KEY STRATEGIES
10.3 BANGKOK HOSPITAL
- 10.3.1 COMPANY OVERVIEW
- 10.3.2 FINANCIAL OVERVIEW
- 10.3.3 PRODUCTS OFFERED
- 10.3.4 KEY DEVELOPMENTS
- 10.3.5 SWOT ANALYSIS
- 10.3.6 KEY STRATEGY
10.4 RAFFLES MEDICAL GROUP
- 10.4.1 COMPANY OVERVIEW
- 10.4.2 FINANCIAL OVERVIEW
- 10.4.3 PRODUCTS OFFERED
- 10.4.4 KEY DEVELOPMENTS
- 10.4.5 SWOT ANALYSIS
- 10.4.6 KEY STRATEGIES
10.5 ASKLEPIOS KLINIKEN GMBH & CO. KGAA
- 10.5.1 COMPANY OVERVIEW
- 10.5.2 FINANCIAL OVERVIEW
- 10.5.3 PRODUCTS OFFERED
- 10.5.4 KEY DEVELOPMENTS
- 10.5.5 KEY STRATEGIES
10.6 MOUNT ELIZABETH HOSPITALS
- 10.6.1 COMPANY OVERVIEW
- 10.6.2 FINANCIAL OVERVIEW
- 10.6.3 PRODUCT OFFERED
- 10.6.4 KEY DEVELOPMENTS
- 10.6.5 KEY STRATEGIES
10.7 MEDANTA
- 10.7.1 COMPANY OVERVIEW
- 10.7.2 FINANCIAL OVERVIEW
- 10.7.3 PRODUCTS OFFERED
- 10.7.4 KEY DEVELOPMENTS
- 10.7.5 KEY STRATEGIES
10.8 MANIPAL HEALTH ENTERPRISES PVT LTD
- 10.8.1 COMPANY OVERVIEW
- 10.8.2 FINANCIAL OVERVIEW
- 10.8.3 PRODUCTS OFFERED
- 10.8.4 KEY DEVELOPMENTS
- 10.8.5 KEY STRATEGIES
10.9 FORTIS HEALTHCARE
- 10.9.1 COMPANY OVERVIEW
- 10.9.2 FINANCIAL OVERVIEW
- 10.9.3 SERVICES OFFERED
- 10.9.4 KEY DEVELOPMENTS
- 10.9.5 SWOT ANALYSIS
- 10.9.6 KEY STRATEGIES
10.10 SAMITIVEJ HOSPITAL
- 10.10.1 COMPANY OVERVIEW
- 10.10.2 FINANCIAL OVERVIEW
- 10.10.3 SERVICES OFFERED
- 10.10.4 KEY DEVELOPMENTS
- 10.10.5 KEY STRATEGIES

11 DATA CITATIONS